Zhengye Biotechnology Holding (ZYBT) Non-Current Debt (2023 - 2025)

Zhengye Biotechnology Holding has reported Non-Current Debt over the past 3 years, most recently at $1.2 million for Q4 2025.

  • Quarterly Non-Current Debt rose 86.73% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, up 86.73% year-over-year, with the annual reading at $1.3 million for FY2025, 92.4% up from the prior year.
  • Non-Current Debt was $1.2 million for Q4 2025 at Zhengye Biotechnology Holding, up from $656000.0 in the prior quarter.
  • Over five years, Non-Current Debt peaked at $1.2 million in Q4 2025 and troughed at $54582.7 in Q4 2023.
  • The 3-year median for Non-Current Debt is $662117.7 (2024), against an average of $656650.7.
  • Year-over-year, Non-Current Debt surged 1124.26% in 2024 and then soared 86.73% in 2025.
  • A 3-year view of Non-Current Debt shows it stood at $54582.7 in 2023, then surged by 1124.26% to $668235.5 in 2024, then soared by 86.73% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Non-Current Debt are $1.2 million (Q4 2025), $656000.0 (Q2 2025), and $668235.5 (Q4 2024).